Manulife Financial (MFC.TO) Buy, Sell or Hold

Home

Daily Stock Opinions and Ratings

Manulife Financial (MFC.TO)

57.04

+0.49 (0.87%)

as of Jun 25, 2026, 8:00:00 pm Market Open.

1634 watching

Investor Insights

Jun 25, 2026, 12:00 am

This summary was created by AI, based on 28 opinions in the last 12 months.

Manulife Financial (MFC) has garnered mixed opinions from market experts. Many analysts recognize MFC's potential, particularly highlighting its growth in Asia and successful capital generation from legacy businesses. The consensus seems to indicate a solid long-term investment due to its steady dividend yield, with several experts suggesting that patience may be required as the stock navigates short-term fluctuations. Despite some concerns about past performance and market positioning against competitors, the company's strategy and management is viewed positively. Analysts mention the current valuation as reasonable compared to peers, suggesting MFC is a better option for income rather than growth. Overall, there is a cautious optimism about MFC's capabilities and future direction.

Consensus

Hold

Valuation

Fair Value

Similar

SLF-T

PAST TOP PICK

(A Top Pick Jul 16/18, Up 7%) He still recommends it and the insurance space in general. It trades just over book value and has a yield of 4%. There is good growth in Asia and they have expanded into Euroasia as well. A well run company that has managed well since the 2008 crisis. One of his favorites.

Wealthica Track your Stocks in your Watch List

BUY

A Canadian stalwart in insurance. It's much more sensitive to the equity markets than other financial stocks, so if the US cuts rates, MFC will be a little negative for Canadian banks, but a little positive for the insurers, including MFC. That lawsuit last Q4 knocked 10% off its market cap, though they wont that suit and MFC stock has since recovered.

DON'T BUY

Has recovered this year. Issue is that it's hard in a low interest world. Most attractive things are Asian businesses and wealth management. His preference is to go with a pure play investment manager. Stock is cheap. Good yield of about 4-5%. But there isn't enough growth for him.

PAST TOP PICK

(A Top Pick Jul 26/18, Up 4%) Trading at 7.7x, extraordinarily cheap. Growing at 9%, with 10% annual dividend growth. Litigation overhang has passed. Still a good place. He's not letting the market bully him out of the stock.

PAST TOP PICK

(A Top Pick Jul 03/18, Up 6%) He is surprised the stock has not done better. They are looking to divest some of their US divisions, which he sees as having weighed the company down. The new CEO has been working hard and he expects to come up with some good strategies going forward.

COMMENT

Good earnings and profits in the last eight quarters and pays a good dividend, but the stock flatlines. Why? Its international growth beats any other Canadian lifeco, and their core earnings have been growing in past years. They deserve credit for that. The problem here are low/flat interest rates; lifecos benefit when rates rise.

TOP PICK

It trades at a good 10x earnings with fine growth ahead. They're particularly growing in Asia. They're serial dividend inceasers, currently paying 4.1%. (Analysts’ price target is $28.74)

TOP PICK

Pays a 4.2% dividend and trades at 1.1x book value, lower than other Canadian lifecos and MFC's own historic average. The new CEO is making steady progress in freeing up regulatory capital, accelerating growth in some segments, being more expense-efficient and pushing digial engagement with customers. (Analysts’ price target is $28.74)

TOP PICK

As cheap a financial as you can find. Nice yield. Earnings are actually rising. Problems with the hedge fund are in the past. Yield is 4.16%. (Analysts’ price target is $28.74)

PAST TOP PICK

(A Top Pick Jul 10/18, Up 5%) She still likes it. MFC Asia is doing a good job. It trades at a very attractive multiple. Earnings growth should pick up.

PAST TOP PICK

(A Top Pick May 24/19, Up 6%) The momentum is strong with good volume. It's been on an uptrend since late-2018. He would not sell it here.

BUY

It's done a nice job coming out of the Recession when their shares fell to $4, but the whole financial sector faces limited growth. However, their Asian division is a growth driver, and they are freeing up capital from their U.S. operations. The share price will grind higher and pays a decent dividend over 4%. His price target is the upper-$20's in 18 months or so.

BUY

They are growing the global operations nicely. He added to it recently. He also owns SLF-T. They are both great companies but he is adding more to MFC-T right now.

COMMENT

MFC-T is the country's biggest life insurance company. He owns Sunlife instead as he feels it is better managed.

WAIT

He almost bought during the recession -- it would have been a great buy then. He would wait on the common stock today. He likes the preferred shares as he likes the income they provide -- with a yield of 5% or more.

Showing 376 to 390 of 2,281 entries

Most Recent Experts

The Panic-Proof Portfolio (Stockchase Research)

Stockchase Premium

Greg Newman

Scotia Wealth Management

The Weekly Buzzing Stocks by Billy Kawasaki

Stockchase

Brendan Caldwell

Caldwell Securities

Liz Young, Head of investment strategy at SoFi

SoFi

Stockchase, in its reporting on what has been discussed by individuals on business television programs (in particular Business News Network), neither recommends nor promotes any investment strategies.

We paraphrase the experts by hand, we watch the shows and write down what we understood from the experts’ comments. We are human and can make mistakes, help us fix any errors. If you see something that you know is not right or if there is a problem with the site, feel free to email us at : [email protected].

Manulife Financial (MFC.TO)